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Abstract
Background: A tracheobronchial lesion observed during an endoscopic examination is usually sampled by the
pulmonologist and sent to the pathologist for microscopic examination. Adipocytes may be observed in the
lamina propria of tracheobronchial biopsies, which may complicate diagnosis of sampled lesions because
these adipose cells may be part of the lesion (lipoma or pulmonary hamartoma), but may also be a normal
component of the bronchial mucosa. Because endoscopic samples frequently miss their target, adipocytes
observed in such biopsies usually lead to uncertainty regarding diagnosis. Both pulmonary hamartomas and
lipomas have a high frequency of translocations involving HMGA2, resulting in over expression of the fusion
protein. The literature suggests that only 31% of tracheobronchial lipomas are correctly diagnosed on biopsy,
sometimes leading to unnecessary aggressive surgical resection.
Methods: We performed retrospective study of tracheo-bronchial biopsies containing adipocytes using HMGA2
immunostaining in order to define their nature and to assess the diagnostic utility of this marker.
Results: In total, 13 lesions biopsied in 12 patients and containing adipocytes were immunostained for HMGA2.
Nuclear immunostaining was detected in 7 out of the 13 lesions (54%), allowing us to diagnose a lipoma or hamartoma.
Conclusion: HMGA2 immunostaining is an affordable and straightforward technique for accurate description of biopsies
containing adipose cells. When positive, a diagnosis of benign adipose lesion can be made with confidence since
well-differentiated liposarcomas have never been described in the tracheobronchial tree. Our work enabled us to
diagnose a benign adipose lesion in 54% of cases, above the rate of 31% reported in the literature, based solely
on morphological analysis. Overall, HMGA2 immunostaining could help pathologists to provide accurate diagnosis of
tracheobronchial adipose lesions, leading to conservative treatment, for the overall benefit of patients.
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Background
A tracheobronchial lesion observed during an endoscopic
examination is usually sampled by the pulmonologist and
sent to the pathologist for microscopic examination. Adi-
pocytes may be observed in the lamina propria, which
may complicate diagnosis of sampled lesions. These adi-
pose cells may be part of the lesion (lipoma or pulmonary
hamartoma), but may also be a normal component of the
bronchial mucosa (Fig. 1), leading to uncertainty regarding
diagnosis because endoscopic samples frequently miss
their target (Fig. 2).
Bronchial biopsy demonstrates a low rate of accuracy
for the diagnosis of lipoma, 31% according to Muraoka et
al. [1]. Therefore, it is crucial to make an accurate diagno-
sis of lipoma on biopsy, as this allows the pathologist to
exclude epithelial malignant lesions and to propose con-
servative treatment such as endoscopic resection [1, 2].
The tracheobronchial tree is rarely involved in adipose
lesions, accounting for 0.1 to 0.5% of all pulmonary le-
sions [3, 4]. Conversely, pulmonary hamartomas are the
most common benign pulmonary neoplasms [5]. Both
pulmonary hamartomas [6–9] and lipomas [10, 11] have
a high frequency of translocations involving the HMGA2
(High Mobility Group A2) gene, resulting in over ex-
pression of the fusion protein.
This over expression is detectable by immunohisto-
chemical techniques on formalin-fixed paraffin-embedded
tissues. The anti-HMGA2 primary antibody (1: 500;
59170AP, Biocheck, Foster City, CA, USA) is a validated
clone for detection of HMGA2 expression in formalin-
fixed paraffin-embedded tissues [12].
Over the past few years, we have encountered adipose
cells on small tracheobronchial biopsies. Given the re-
cent availability of HMGA2 immunostaining, we
performed a retrospective analysis to provide an accurate
description of these samples. In addition, we assessed
the diagnostic utility of HMGA2 immunohistochemistry
specifically in cases of tracheobronchial biopsies.
Methods
Selection of cases
Cases of tracheobronchial biopsies performed between 01/
01/1990 and 01/03/2016 were retrieved from the anatomic
pathology database of Rouen University Hospital. Biopsies
coded as bronchial hamartoma (24 cases), bronchial
lipoma (0 case), tracheal hamartoma (1 case) and tracheal
lipoma (1 case) were included in the present study. The
corresponding pathology reports were retrieved. Three
cases were excluded as the endoscopic appearance was
normal (systematic biopsies), but were used as negative
controls. To sum up, the criteria for including cases were:
1) a biopsied macroscopic lesion during bronchoscopy and
2) adipose cells in the lamina propria of the biopsy.
Then, the original hematoxylin and eosin stained slides
were retrieved and examined by two experienced pathol-
ogists (N.P. and J.C.S.). Finally, ten cases were excluded
since only cartilaginous or fibrous lesions, but no adi-
pose lesions, were observed.
Demographics and clinical data (age at biopsy, sex and
presentation) of patients were extracted from clinical in-
formation available in pathology and clinical reports.
Formalin-fixed paraffin-embedded tissue samples of tra-
cheobronchial biopsies were retrieved for immunostaining.
Twenty resection specimens of lung carcinoma with
adipose tissue observed on samples of the tumor-free
bronchial surgical margins were used as a control for
normal adipose tissue from the tracheobronchial tree
(example in Fig. 1). This control group was chosen
among 124 retrospective resection specimens analyzed
in our department in 2015 and 2016.
Immunohistochemistry
Formalin-fixed paraffin-embedded tissue samples of tra-
cheobronchial biopsies from included cases were re-
trieved and 4 μm slide sections were cut. Slides were
immunostained using the anti-HMGA2 primary anti-
body (1: 500; 59170AP, Biocheck, Foster City, CA, USA).
Deparaffinization, antigen retrieval and immunostaining
were performed using a Benchmark ULTRA device
(Ventana-Roche; Switzerland). Slides were heated to 72 °C,
then incubated during 30 min with the antibody, next
rinsed in buffer solution.
Positive control consisted of section of intra-muscular
lipoma. Negative control consisted of normal adipose
tissue of a resection specimen for skin melanoma.
A lesion was considered as HMGA2 positive when at
least one cell nucleus was stained per high-power field,
according to Dreux et al. [12].
Fig. 1 Example of adipose cells in the lamina propria of a normal
bronchus. This image was obtained from the bronchial margin of a
resection specimen of a lobe for carcinoma. The lamina propria
contains adipose cells, just above the cartilaginous ring (square). The
slide was stained by hematoxylin and eosin. Scale bar 50 μm
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Results
In total, 13 lesions from 12 patients were included in
our study (Table 1). One patient presented with two dis-
tinct lesions sampled during the same bronchoscopy,
one in the right lower lobe (lesion 4) and one in the left
upper lobe (lesion 5). One lesion (case 9) was sampled
twice, one month apart. Mean age at biopsy was 57 years
(standard deviation = 19). Seventy-five percent of pa-
tients were men (9 cases) and 25% were women (3
cases). Forty-six percent (n = 6) of lesions were located
in the left lung (2 in the left upper lobe, 4 in the left
lower lobe), 38% (n = 5) in the right lung (3 in the right
Fig. 2 Main hypotheses when adipocytes are observed on tracheobronchial biopsies
Table 1 Clinical and pathologic characteristics of the 13 included lesions
Case Sex Age (years) Presentation Location HMGA2 staining Remark
1 M 61 Smooth endobronchial lesion. Right upper lobe POSITIVE
2 M 65 ENT carcinoma. Hemoptysis. Suspicious
endobronchial lesion.
Right upper lobe POSITIVE
3 M 50 Hemoptysis. Small sessile endobronchial lesion. Left lower lobe POSITIVE
4 M 55 COPD and obesity. Acute pulmonary insufficiency.
Non suspicious endobronchial lesion.
Right lower lobe NEGATIVE Superficial epithelial
cells were stained.
5 M 55 COPD and obesity. Acute pulmonary insufficiency.
Non suspicious endobronchial lesion.
Left upper lobe NEGATIVE Superficial epithelial
cells were stained.
6 M 58 Small cell neuroendocrine carcinoma. Endoscopic
evaluation after 6 courses of chemotherapy.
Left lower lobe NEGATIVE
7 M 64 Squamous cell carcinoma of the left upper lobe.
Lipomatous endobronchial lesion.
Middle lobe POSITIVE Superficial epithelial
cells were stained.
8 F 44 Ankylosing spondylarthritis. Dyspnea. Small non
suspicious endobronchial lesion.
Trachea NEGATIVE Superficial epithelial
cells were stained.
9 F 77 Smooth pediculated endobronchial lesion. Fat
density on imaging.
Left lower lobe NEGATIVE Superficial epithelial
cells were stained.
10 M 43 Endobronchial lesion. Left upper lobe POSITIVE
11 M 77 Pediculated endobronchial lesion causing complete
bronchial obstruction. Calcification on imaging.
Adipose lesion macroscopically.
Right upper lobe POSITIVE
12 F 9 Localized bronchiectasis. Round whitish lesion
causing complete bronchial obstruction.
Left lower lobe NEGATIVE
13 M 76 Incidental. Endoscopy for exposure to asbestos.
Smooth endotracheal lesion with yellowish area
macroscopically.
Trachea POSITIVE
Lesion 4 and lesion 5 were presented by the same patient
M male, F female, COPD chronic obstructive lung disease
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upper lobe, 1 in the middle lobe and 1 in the right lower
lobe) and only 15% (n = 2) were tracheal. Three patients
had a history of cancer: case 2 with ENT carcinoma, case
6 with small cell neuroendocrine carcinoma and case 7
with bronchial squamous cell carcinoma. Description on
computerized tomography scanner were retrieved in
medical records for only 2 lesions (cases 9 and 11).
Nuclear immunostaining was detected in 7 out of
the 13 lesions, i.e. in 54% (example in Fig. 3, illustrat-
ing case 13). The two lesions presented by the same
patient (cases 4 and 5) were both negative and lesion
9, sampled twice, was negative for both specimens. In
6 cases (46%), the nucleus of superficial normal epithelial
cells was stained, without any correlation with positivity
or negativity of the underlying lesion (example in Fig. 4, il-
lustrating case 6). HMGA2 staining was negative in the
adipose tissue observed on the twenty tumor-free bron-
chial surgical margins of resection specimens of lung car-
cinoma and on the 3 cases excluded initially because of
normal endoscopic appearance.
Discussion
Normal adipose tissue is not reported in textbooks on
normal human histology at the chapter Lung [13]. How-
ever, experience in our laboratory has shown that adipo-
cytes may sometimes be observed in the bronchial
lamina propria (Fig. 1). The presence of adipocytes may
complicate accurate description of the biopsied lesion
(Fig. 2): is this tissue normal or not? In other words, is it
a tracheobronchial lipoma or a pulmonary hamartoma
or did the pulmonologist fail to sample the lesion? In-
deed, the presence of normal adipose tissue in the lam-
ina propria of the bronchi can sometimes mislead the
pathologist into making an erroneous diagnosis of benig-
nity if the endoscopist fails to sample the lesion of
interest.
HMGA2 plays a role in mammalian growth [14, 15]. It
is reported to be expressed in neoplastic tissues and
seems to play a role in cell growth, differentiation and
tumorigenesis through modification of chromatine
structure [16]. Conversely, according to the literature
HMG proteins are not expressed in normal adult tissue
[17]. HMGA2 immunostaining is routinely used in soft
tissue pathology in order to help to distinguish between
normal adipose tissue (HMGA2 negative) and adipose
tumor such as lipoma or liposarcomas (HMGA2 usually
positive) [12].
According to data previously reported in the literature
[1], men were more represented than women in these se-
lected cases (9 out of 12 patients, i.e. 75%) and interest-
ingly, all lesions positive for HMGA2 staining were
presented by men only. In accordance with the literature,
lesions positive for HMGA2 staining were mainly located
in the right lung (4 out of 7 lesions, i.e. 57%), with only 2
cases (29%) in the left lung and 1 in the trachea.
In 6 cases (46%), the nucleus of superficial normal epi-
thelial cells was weakly stained, without any correlation
with positivity or negativity of the underlying lesion (ex-
ample in Fig. 3, illustrating case 6). We believe that this
unspecific signal is a potential pitfall and should be kept in
mind when handling small, dissociated biopsy cores be-
cause it may lead to misdiagnose lipoma or hamartoma if
the epithelial nature of the positive cells is overlooked.
This faint staining was unexpected as HMGA2 expression
is not described in normal adult tissue [17]. Additional re-
search is needed to explain our observation and to deter-
mine whether staining was genuine or unspecific.
A radiological description was retrieved in medical re-
cords for only two cases [9, 11] and to our knowledge,
no patient underwent surgical resection. Therefore, there
exists a theoretical risk that included lesions were nei-
ther lipoma nor hamartoma. However, for the majority
of remaining lesions, the macroscopic appearance fa-
vored such a diagnosis, with reassuring terms used by
the endoscopisc (Table) and all biopsies contained adi-
pose cells in the lamina propria.
Fig. 3 Example of an adipose lesion positive for HMGA2 immunostaining (case 13). This image was obtained from biopsies of a tracheal lesion.
Hematoxylin and eosin staining (a) and HMGA2 immunostaining counterstained by hematoxylin (b). The lesion is located in the lamina propria
and consists of sheets of adipose cells surrounding tracheal glands. The nucleus of adipose cells positive for HMGA2 immunostaining. Scale
bar 100 μm
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To the best of our knowledge, this is the first series of
tracheobronchial biopsies containing adipose tissue ana-
lyzed by HMGA2 immunostaining. Our work has enabled
retrospective confirmation of the lipomatous or hamarto-
matous nature of the lesions in 54% of cases, above the
rate of 31% reported in the literature, based solely on mor-
phological analysis [1]. In this Japanese review, 69% of bi-
opsies led to an erroneous diagnosis, with even 6.25% of
cases diagnosed with malignancy, leading to useless and
dangerous treatment [1]. The number of cases included in
our study is quite small and results should be validated in
a larger cohort. However, we are convinced HMGA2
immunostaining is a straightforward and affordable
method compared to fluorescent in situ hybridization for
accurate description and diagnosis of these rare cases
(Fig. 5). When positive, a diagnosis of benign lesion
(lipoma or pulmonary hamartoma) can be made with
confidence since well-differentiated liposarcomas have
never been described in the tracheobronchial tree [18].
Conversely, when negative, uncertainty remains because
roughly 20% of lipomas [12] and 30% of pulmonary
hamartomas [19] are negative for this marker. This is of
great importance since diagnosis of such benign lesions by
biopsy significantly impacts treatment.
Fig. 4 Example of an adipose lesion negative for HMGA2 immunostaining (case 6). This image was obtained from biopsies of a bronchial lesion
located in the left lower lobe. Hematoxylin and eosin staining (a) and HMGA2 immunostaining counterstained by hematoxylin (b). The lesion is
located in the lamina propria and consists of sheets of adipose cells. The nucleus of adipose cells negative for HMGA2 immunostaining. In
contrast, some nuclei of superficial epithelial cells were positive. Scale bar 50 μm
Fig. 5 Proposal for an algorithm when adipocytes are observed on tracheobronchial biopsies
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Conclusion
In conclusion, we recommend performing HMGA2 stain-
ing whenever encountering adipocytes on tracheobron-
chial biopsies. This could help pathologists to provide
accurate diagnosis of benign lesions and lead to conserva-
tive treatment, for the overall benefit of patients.
Abbreviation
HMGA: High Mobility Group A2
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